Noor Trends News, Technical Analysis, Educational Tools and Recommendations
U.S. President Donald Trump on Thursday unveiled TrumpRx.gov, a new website aimed at giving Americans access to discounted prescription medicines, marking a central pillar of his renewed push to lower drug prices in the United States.
The launch was announced during a White House event attended by Centers for Medicare & Medicaid Services (CMS) Administrator Dr. Mehmet Oz and National Design Studio Director and Airbnb co-founder Joe Gebbia.
“People are going to save a lot of money and be healthy,” Trump said during the event.
Drugmakers strike tariff-linked pricing deals
The initiative is underpinned by agreements between the Trump administration and 16 of the world’s largest pharmaceutical companies, which have agreed to so-called “most-favored nation” pricing arrangements. Under these deals, drugmakers will lower prices for Americans in exchange for exemptions from certain U.S. tariffs.
The agreements apply to the government’s Medicaid program and, through TrumpRx, to consumers paying out of pocket without insurance.
Among the most prominent participants are Eli Lilly and Novo Nordisk, which agreed to significantly cut prices on popular GLP-1 weight-loss drugs. According to the administration, average monthly prices for Americans would fall to between $149 and $350.
Novo Nordisk and Eli Lilly have increasingly focused on direct-to-consumer sales, which the companies say now account for more than 10% of total revenue. Novo’s Wegovy pill, launched last month, is currently sold exclusively through direct channels while insurers finalize coverage decisions.
“We’re continuing to make it easier for people to access our authentic, FDA-approved medicines by expanding availability through multiple, convenient options,” said Chris Pernie, Novo Nordisk’s associate vice president for U.S. public affairs.
“The launch of TrumpRx will further extend patients’ reach to Ozempic and Wegovy, including the newly approved Wegovy pill, at our self-pay prices,” he added.
How TrumpRx works
According to STAT News, the platform is powered by prescription savings site GoodRx. TrumpRx itself will not sell medicines directly, but instead redirect consumers to third-party sites where the drugs can be purchased.
Other pharmaceutical companies signing on to the initiative include Pfizer, AstraZeneca, Merck, and GSK. Pfizer said it launched its TrumpRx program on Thursday and will offer more than 30 medicines at discounted prices.
In addition to obesity and diabetes drugs, medicines listed for availability include Merck’s Januvia, Sanofi’s blood thinner Plavix, GSK’s asthma inhaler Advair Diskus 500/50, Amgen’s cholesterol drug Repatha, and Gilead’s hepatitis C treatment Epclusa. Fertility medications such as EMD Serono’s Gonal-F and Merck’s Cetrotide are also included, the White House said.
Savings still unclear
Despite the fanfare, analysts cautioned that the actual savings for many consumers remain uncertain. TrumpRx is aimed primarily at people buying drugs without insurance, meaning purchases generally will not count toward insurance deductibles.
U.S. consumers typically pay far more for prescription medicines—often nearly three times as much as patients in other developed countries—an issue Trump has repeatedly highlighted in pressuring drugmakers to cut prices.
Cubanski noted that while the program may benefit some patients, it should not be viewed as a comprehensive solution to high drug costs.
